Kamada (KMDA) Selling, General & Administrative (2012 - 2026)
Kamada's Selling, General & Administrative was $5.82 million in the quarter ended Jun 30, 2026, up 43.1% from $4.07 million a year earlier and up 11.3% from the prior quarter.
Powered by 
Analysis
Kamada (KMDA) Selling, General & Administrative (2012 - 2026) Analysis & Trends
On a trailing twelve-month basis, Kamada's Selling, General & Administrative was $21.51 million through Jun 30, 2026, up 31.1% year-over-year; for the year ended Dec 31, 2025, it came in at $18.72 million, up 19.2% from the prior year.
- Selling, General & Administrative has now increased for ten consecutive years, with a five-year compound annual growth rate of 13.1% (years ended Dec 2020 to Dec 2025).
- In earlier years, Selling, General & Administrative was $15.7 million in the year ended Dec 31, 2024 (+9.2%), $14.38 million in the year ended Dec 31, 2023 (+12.3%), $12.8 million in the year ended Dec 31, 2022 (+1.3%) and $12.64 million in the year ended Dec 31, 2021 (+24.6%).
- The figure for the quarter ended Jun 30, 2026 marks the highest quarterly Selling, General & Administrative since the quarter ended Sep 30, 2017.
- Compared with a year earlier, Selling, General & Administrative has increased for 14 straight quarters, with growth averaging 20.1% over the last eight quarters.
- The best year-over-year quarter for Selling, General & Administrative over five years was the quarter ended Jun 30, 2026 (growth of 43.1%); the worst was the quarter ended Dec 31, 2022 (a decline of 13.3%).
- Per Business Quant data, KMDA's Selling, General & Administrative in the three quarters before the quarter ended Jun 30, 2026 was $5.23 million (quarter ended Mar 31, 2026), $5.64 million (quarter ended Dec 31, 2025) and $4.82 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 3.13 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 6.29 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 4.09 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 2.89 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 5.11 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 1.68 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 1.64 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 3.28 Bn |
| 10 | Kamada | 441.57 Mn | 150.63 Mn | 22.47 Mn | 5.82 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.82 Mn |
| Mar 31, 2026 | 5.23 Mn |
| Dec 31, 2025 | 5.64 Mn |
| Sep 30, 2025 | 4.82 Mn |
| Jun 30, 2025 | 4.07 Mn |
| Mar 31, 2025 | 4.20 Mn |
| Dec 31, 2024 | 4.12 Mn |
| Sep 30, 2024 | 4.01 Mn |
| Jun 30, 2024 | 3.78 Mn |
| Mar 31, 2024 | 3.79 Mn |
| Dec 31, 2023 | 3.78 Mn |
| Sep 30, 2023 | 3.70 Mn |
| Jun 30, 2023 | 3.48 Mn |
| Mar 31, 2023 | 3.42 Mn |
| Dec 31, 2022 | 3.32 Mn |
| Sep 30, 2022 | 3.17 Mn |
| Jun 30, 2022 | 3.31 Mn |
| Mar 31, 2022 | 3.01 Mn |
| Dec 31, 2021 | 3.83 Mn |
| Sep 30, 2021 | 2.69 Mn |
API Access
Kamada Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=KMDA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "KMDA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=KMDA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();